BIRC5 and breast cancer: The divergent functions of nuclear and cytoplasmic Survivin are highlighted in studies on breast cancer where elevated levels of cytoplasmic Survivin correlate with a poorer patient outcome owing to its anti-apoptotic function, while increased nuclear Survivin is correlated with a better outcome [31,33,48–51].